Bank of Montreal
KZR

Bank of Montreal’s Kezar Life Sciences KZR Stock Holding History

Bank of Montreal’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,219
Closed -$39.3K – 4161
2023
Q1 		$39.3K Buy
+1,219
New +$70.5K ﹤0.01% 3414
2021
Q2 		– Sell
-1,077
Closed -$67K – 4342
2021
Q1 		$67K Sell
1,077
-395
-27% -$23.1K ﹤0.01% 3583
2020
Q4 		$82K Buy
1,472
+355
+32% +$19.7K ﹤0.01% 3688
2020
Q3 		$58K Sell
1,117
-51
-4% -$2.44K ﹤0.01% 3365
2020
Q2 		$60K Buy
1,168
+331
+40% +$16.7K ﹤0.01% 3345
2020
Q1 		$32K Sell
837
-198
-19% -$8.05K ﹤0.01% 3079
2019
Q4 		$42K Buy
1,035
+865
+509% +$26.6K ﹤0.01% 3923
2019
Q3 		$6K Buy
170
+39
+30% +$1.88K ﹤0.01% 4523
2019
Q2 		$10K Buy
+131
New +$20.4K ﹤0.01% 4522
2019
Q1 		– Sell
-7
Closed -$2K – 4535
2018
Q4 		$2K Buy
7
+3
+75% +$733 ﹤0.01% 4381
2018
Q3 		$1K Buy
+4
New +$698 ﹤0.01% 4551

Other funds holding KZR

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of Montreal's KZR Position: Q2 2023 in Review

Bank of Montreal sold out of Kezar Life Sciences (KZR) in Q2 2023, closing a stake of 1,219 shares — an estimated $39.3K sold.

Bank of Montreal first reported a position in KZR in Q3 2018 and held it in 11 quarters. The position peaked at $82K in Q4 2020. 104 funds tracked by Wall St. Rank hold KZR as of Q2 2023.

  • Bank of Montreal reported no remaining Kezar Life Sciences position as of Q2 2023 after selling out during the quarter.
  • Bank of Montreal sold 1,219 Kezar Life Sciences shares in Q2 2023, an estimated $39.3K.
  • Bank of Montreal first reported a position in Kezar Life Sciences in Q3 2018 and held it in 11 quarters.
  • Bank of Montreal's Kezar Life Sciences position peaked at $82K in Q4 2020.
  • 104 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2023.

Based on Bank of Montreal's 13F filing for Q2 2023, filed 2 Aug 2023.